维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Hopewell JC"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Genetic variants associated with Lp(a) lipoprotein level and coronary disease显示文摘	Clarke R Peden JF Hopewell JC	2009	N Engl J Med2009，361，26：	1
2	Impact of lipoprotein (a) levels and apolipoprotein (a) isoform size on risk of coronary heart disease 显示文摘	Hopewell JC Seedorf U Farrall M	2014	J Intern Med2014，276，3：	1
3	Genetic variants associ- ated with Lp(a) lipoprotein level and coronary disease显示文摘	Clarke R Peden JF Hopewell JC	2009	N En- gl J Med2009，361，26：	1
4	Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease显示文摘	Hopewell JC Seedorf U Farrall M	2014	J Intern Med2014，276，3：	1
5	No Impact of KIF6 geno-type on vascular risk and statin response among 18 348 randomizedpatients in the heart protection study显示文摘	Hopewell JC Parish S Clarke R	2011	J Am Coll Cardiol2011，57，20：	1
6	Lipoprotein (a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study 显示文摘	Hopewell JC Clarke R Parish S	2011	Circ Cardiovasc Genet2011，4，1：	1
7	Genetic variants associated with Lp (a) lipoprotein level and coronary disease 显示文摘	Clarke R Peden JF Hopewell JC	2009	N Engl J Med2009，361，26：	1
8	Effects of extended- release niacin with laropiprant in high-risk patients 显示文摘	Landray M J Haynes R Hopewell JC	2014	N Engl J Med2014，371，3：	1
9	Genetic variants associated with Lp(a) lipoprotein level and coronary disease显示文摘	Clarke R Peden JF Hopewell JC	2009	N Engl J Med2009，361，：	1
10	Genetic variants associatedwith Lp(a)lipoprotein level and coronary disease显示文摘	Clarke R Peden JF Hopewell JC		N Engl J0，，：	1
11	Genetic variants associated with Lp(a) lipoprotein level and coronary disease显示文摘	Clarke R Peden JF Hopewell JC	2009	N Engl J Med2009，361，26：	1
12	Effects of extended -release niacin with laropiprant in high-risk patients 显示文摘	Landray M J Haynes R Hopewell JC	2014	N Engl J Med2014，371，3：	1
13	Genetic variants associated with Lp(a) lipopretein level and coronary disease显示文摘	Clarke R Peden JF Hopewell JC	2009	N Engl J Med2009，361，26：	1
14	HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/lar-opiprant:trial design,pre-specified muscle and liver outcomes,and reasons for stopping study treatment显示文摘	Haynes R Jiang LX Hopewell JC		0，，17：	1
15	HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/ laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment 显示文摘	Haynes R Jiang L Hopewell JC	2013	Eur Heart J2013，34，17：	1
16	A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease显示文摘	Peden JF Hopewell JC Saleheen D	2011	Nature Genet2011，43，4：	1
17	Genetic variants associ- ated with Lp(a) lipoprotein level and coronary disease显示文摘	Clarke R Peden JF Hopewell JC	2009	N Engl J Med2009，361，26：	1
18	Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig显示文摘	Kato-Maeda M Shanley CA Ackart D Jarlsberg LG Shang S Obregon-Henao A Harton M Basaraba RJ Henao-Tamayo M Barrozo JC Rose J Kawamura LM Coscolla M Fofanov VY Koshinsky H Oagneux S Hopewell PC Ordway DJ Orme IM	2012	Clin Vaccine Immunol2012，19，8：	1
19	No Impact of KIF6 geno-type on vascular risk and statin response among 18 348 randomizedpatients in the heart protection study显示文摘	Hopewell JC Parish S Clarke R	2011	J Am Coll Cardiol2011，57，20：	1
20	No impact of KIF6 genotype on vascular risk and statin response among 18 348 randomized patients in the heart protection study显示文摘	Hopewell JC Parish S Clarke R		0，，20：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示